Clinical trial

GSK239512 DDI Study

NCT01802931

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2013-01-07

PhasePHASE1

Study timeline

Study start (actual)2013-01-07Date precision: day

Registry last updated2017-07-26

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Multiple Sclerosisverified · MONDO: multiple sclerosis

Interventions

GSK239512DRUG

ketoconazoleDRUG · verified · RxNorm: ketoconazole

Sponsors & collaborators

GlaxoSmithKlinelead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01802931 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.